Equities

Panacea Biotec Ltd

PANACEABIO:NSI

Panacea Biotec Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)143.65
  • Today's Change-2.85 / -1.95%
  • Shares traded87.78k
  • 1 Year change+19.71%
  • Beta1.0984
Data delayed at least 15 minutes, as of Apr 26 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • PANACEABIO:NSI price moved over +5.68% to 145.95
  • PANACEABIO:NSI price falls below 50-day moving average to 144.15 at 13:57 BST
  • PANACEABIO:NSI trading volume exceeds daily average by +16.13%
  • PANACEABIO:NSI price rises above 50-day moving average to 144.95 at 12:30 BST
  • PANACEABIO:NSI price rises above 50-day moving average to 145.20 at 12:29 BST
  • PANACEABIO:NSI price rises above 15-day moving average to 145.95 at 12:30 BST
  • PANACEABIO:NSI price rises above 15-day moving average to 138.85 at 16:09 BST

Key statistics

On Friday, Panacea Biotec Ltd (PANACEABIO:NSI) closed at 143.65, 25.79% above the 52 week low of 114.20 set on May 22, 2023.
52-week range
Today
114.20May 22 2023202.50Jan 04 2024
Open147.15
High148.50
Low143.10
Bid143.65
Offer143.65
Previous close146.50
Average volume121.23k
Shares outstanding61.25m
Free float16.07m
P/E (TTM)--
Market cap8.80bn INR
EPS (TTM)-1.89
INR
Data delayed at least 15 minutes, as of Apr 26 2024 11:21 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.